Bumrungrad announces the direction in 2022 - shifting the future of healthcare

Economy News Tuesday March 1, 2022 13:54 —PRESS RELEASE LOCAL

Bumrungrad announces the direction in 2022 - shifting the future of healthcare

Pharmacist Artirat Charukitpipat (center), CEO of Bumrungrad International Hospital leads the management team, doctors and medical professionals to announce our future direction in 2022. Bumrungrad is determined to be the leader of implementation of Smart Healthcare 5.0 to provide holistic medical care to our patients. We always prioritize the international standards of quality and safety. Bumrungrad is devoted to expanding our centers of excellence to develop expertise in the treatment of every complex medical condition. Bumrungrad will focus on two medical advancements: robotic surgery and genetic testing. We have adopted robotic assisted surgery, using the da Vinci surgical system to perform operations on multiple organ systems. We also provide comprehensive genomic and genetic testing to assess risks of developing hereditary conditions as well as to actively prevent them. These are the highlights of the press conference, "Bumrungrad: Shifting the Future of Healthcare" at Bumrungrad International Hospital.

Photo (from left)

  • Assoc. Prof. Dr. Taveesin Tanprayoon, Chief Medical Officer of Bumrungrad International Hospital
  • Khun Napas Paorohitya, Chief Marketing Officer of Bumrungrad International Hospital
  • Pharmacist Artirat Charukitpipat, CEO of Bumrungrad International Hospital
  • Clinical Prof. Dr. Anusak Yiengpruksawan, Director, Bumrungrad Robotic Surgery Center of Bumrungrad International Hospital
  • Assist. Prof. Dr. Polakrit Teekakirikul, Cardiologist and Medical Geneticist of Bumrungrad International Hospital
  • เว็บไซต์นี้มีการใช้งานคุกกี้ ศึกษารายละเอียดเพิ่มเติมได้ที่ นโยบายความเป็นส่วนตัว และ ข้อตกลงการใช้บริการ รับทราบ